Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Higgins

Showing results (251-260 of 255) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 255 results.
JCI Insight|June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodiesRuth O Payne, Sarah E Silk, Sean C Elias, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Cell|July 26, 2024
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Pageof 26

Showing results (251-260 of 255) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 255 results.
JCI Insight|June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodiesRuth O Payne, Sarah E Silk, Sean C Elias, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Cell|July 26, 2024
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, et al.
Nature Communications|June 7, 2024
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complexBarnabas G Williams, Lloyd D W King, David Pulido, et al.
Pageof 26